Tropical Diseases

Access to Healthcare

Renewing our commitment to neglected tropical disease and malaria elimination

Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.

Access to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical Diseases
Access to Healthcare

Staying one step ahead of the malaria parasite

Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.

Access to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical Diseases
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease

Basel, February 17, 2021 — Novartis today announced that it has entered into a grant agreement with the Bill & Melinda Gates Foundation. As part of the agreement, the foundation will provide funding support for the discovery and development of a single-administration, in vivo gene therapy to cure sickle cell disease (SCD). The project…

Tropical DiseasesInnovationAfricaAccess to Healthcare
Novartis global survey uncovers profound and often under-reported effects on sickle cell disease patients

Basel, December 9, 2019 — “We see sickle cell as a painful disease, but too often we don't translate how that pain affects the lives of our patients – can they go to school, can they work, can they enjoy their families? These are things many of us take for granted,” said Ifeyinwa Osunkwo, MD, MPH, Founder and Director, Sickle Cell Disease…

Tropical DiseasesScientific ResearchAfrica
Access to Healthcare

New drugs could offer hope for malaria patients

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

Disease EradicationGlobal Health PartnershipsMalariaNovartis Social BusinessPatient EducationTropical Diseases
Access to Healthcare

Malaria fighter rides bicycle into battle with disease

Healthcare worker Dismus Mwalukwanda is on the front line of the battle against malaria. Saving lives is his priority.

Access to HealthcareDisease EradicationInfectious DiseasesMalariaNovartis Social BusinessTropical Diseases
Access to Healthcare

A life dedicated to fighting malaria

Lake Victoria in southwestern Kenya is on the front line in the fight against malaria, and Agnes Akoth is a key figure.

Disease EradicationMalariaNovartis Social BusinessTropical Diseases
From Our Labs

Opening chemistry education to the world

Novartis taps MOOC technology to share chemistry education with the world

Drug DiscoveryNovartis Institutes for BioMedical ResearchTropical DiseasesClinical ResearchBiomedical JobsEye Disorders
Discovery

Killing three diseases with one stone in the lab

Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Drug DiscoveryInfectious DiseasesTropical Diseases
Discovery

Experimental treatment clears malaria infections in small clinical study

Compound offers a potential tool for fighting drug-resistant malaria parasites.

Biomedical ResearchNovartis Social BusinessTropical Diseases